Maximilian Trum
University Hospital Regensburg(DE)
Publications by Year
Research Areas
Cardiac electrophysiology and arrhythmias, Diabetes Treatment and Management, Pancreatic function and diabetes, Ion channel regulation and function, Cardiovascular Function and Risk Factors
Most-Cited Works
- → Empagliflozin Reduces Ca/Calmodulin-Dependent Kinase II Activity in Isolated Ventricular Cardiomyocytes(2018)229 cited
- → Empagliflozin Inhibits Na+/H+ Exchanger Activity in Human Atrial Cardiomyocytes(2020)109 cited
- → Cardioprotection by SGLT2 Inhibitors—Does It All Come Down to Na+?(2021)64 cited
- → Empagliflozin Inhibits Cardiac Late Sodium Current by Ca/Calmodulin-Dependent Kinase II(2022)46 cited
- → NCX1 represents an ionic Na+ sensing mechanism in macrophages(2020)38 cited
- → Detrimental proarrhythmogenic interaction of Ca2+/calmodulin-dependent protein kinase II and NaV1.8 in heart failure(2021)26 cited
- → CaMKII and GLUT1 in heart failure and the role of gliflozins(2020)25 cited
- → Empagliflozin Reduces Renal Hyperfiltration in Response to Uninephrectomy, but Is Not Nephroprotective in UNx/DOCA/Salt Mouse Models(2021)24 cited
- → Empagliflozin inhibits increased Na influx in atrial cardiomyocytes of patients with HFpEF(2024)22 cited
- → Inhibition of cardiac potassium currents by oxidation-activated protein kinase A contributes to early afterdepolarizations in the heart(2020)18 cited